India to China Pharmaceutical Export (2026) — $78.0M, 201 Suppliers | TransData Nexus

India to China Pharmaceutical Export (2026) — $78.0M, 201 Suppliers | TransData Nexus | TransData Nexus

Top Pharmaceutical Formulations — India to China

#	Formulation	Value	Share
1	10000 Strips Sildenafil Citrate 100 MG	$5.9M	7.5%
2	Oseltamivir Phosphate Capsules 75 MG (1x10s)	$1.2M	1.6%
3	Oseltamivir Phosphate Capsules 75 MG (1x10's)	$1.1M	1.4%
4	Material No- 44087965 Voriconazole 200mg30fct Cn	$921.5K	1.2%
5	Pretomanid Tablets 200mg 26bt (5212 Packs X 26's=135512 )	$889.8K	1.1%
6	Oseltamivir Phosphate Capsules 75mg (oselvir), Package 10 Capsules/blister	$648.0K	0.8%
7	Oseltamivir Phosphate Capsules 30 MG (1x10's)	$619.6K	0.8%
8	Dymista (azelastine Hydrochloride137mcg+fluticasone Prop: 50mcg(per Spray) (nas…	$603.9K	0.8%
9	Pantoprazole Tablets 40 MG 30's Pack	$603.6K	0.8%
10	Amino Acids (5% W/v) and Sorbitol (5% W/v) Injection 200ml Glass Bottle (celemi…	$540.8K	0.7%
11	Oselavir Solution	$529.8K	0.7%
12	Paliperidone Er Tablets 3mg 14btl Cn (qty: 101376 Pack X 14s-bottle)	$525.1K	0.7%
13	Oseltamivir Phosphate Capsules	$519.0K	0.7%
14	Isoflurane Bulk Other Desc.as Per Invoice Attch.green Card No.420/vsez Dt.10/05…	$495.9K	0.6%
15	Oselavir	$465.3K	0.6%

India exports 20+ pharmaceutical formulations to China with a combined trade value of $78.0M. Key products include Oseltamivir ($1.2M), Voriconazole ($921K), Pantoprazole ($604K), Amino ($541K). These are finished dosage forms — tablets, capsules, injectables, and combination drugs — shipped from Indian manufacturing facilities with FDA, WHO-GMP, and EU GMP certifications. Data from 3,469 verified Indian Customs (DGFT) shipment records.

Top Pharmaceutical Products — India to China Trade Routes

1Oseltamivir$1.2M 2Voriconazole$921K

3Pantoprazole$604K

4Amino$541K

These are the top pharmaceutical products exported from India to China, each with a dedicated trade route analysis page. Click any product to see detailed export data including Indian suppliers, China buyers, regulatory requirements, and logistics for that specific product corridor. Products include Oseltamivir ($1.2M), — all finished pharmaceutical formulations verified from Indian Customs (DGFT) records.

Top Indian Exporters to China

1Dr.reddy's Laboratories Ltd

$10.3M

2Ap Warehousing And Trading Llp

$6.3M

3Mark (india) Formulation

$5.5M

4Sandoz Private Limited

$5.3M

5Cipla Limited

$5.3M

Port Analysis — India to China Pharmaceutical Shipments

Indian Export Ports

HYDERABAD ICD4.5%

SAHAR AIR CARGO ACC (INBOM4)7.4%

J MATADEE - CHENNAI FTZ0.4%

HYDERABAD ICD (INSNF6)1.4%

SAHAR AIR7.9%

China Import Ports

SHANGHAI - PU DONG8.5%

Dalian22.2%

SHANGHAI6.1%

Shenzhen1.4%

DALIAN12.7%

Trade Statistics

Total Value$78.0M

Shipments3,469

Indian Exporters201

China Buyers431

Avg Shipment$22K

Products2,373

Other Destinations

United States$8.8B United Kingdom$1.2B Canada$1.1B France

Last updated: March 28, 2026

India–China Pharmaceutical Trade Corridor Analysis

Historical evolution, India's market position, and recent developments

1Trade Corridor Evolution

The pharmaceutical trade between India and China has experienced significant growth over the past decade. In 2024, India's pharmaceutical exports to China reached approximately $83.99 million, marking a substantial increase from previous years. This upward trajectory reflects the strengthening of bilateral trade relations and India's growing presence in the Chinese pharmaceutical market.

Key milestones include the establishment of the Production Linked Incentive (PLI) scheme by the Indian government, aimed at boosting domestic production and reducing import dependence. This initiative has led to a significant increase in India's exports of active pharmaceutical ingredients (APIs), surpassing imports in the fiscal year 2024-25. Such developments underscore the evolving dynamics of the India-China pharmaceutical trade corridor.

2India's Market Position

India holds a significant position in China's pharmaceutical import landscape. In 2024, China's pharmaceutical imports from India were valued at $135.68 million, indicating a robust demand for Indian pharmaceutical products. This demand is driven by India's competitive pricing, diverse product offerings, and adherence to international quality standards. While other countries also supply pharmaceuticals to China, India's strategic importance is highlighted by its substantial market share and the growing preference for its products.

China Regulatory Landscape for Indian Pharmaceutical Exports

Registration process, GMP requirements, import documentation

1Registration Process

Indian pharmaceutical companies seeking to market their products in China must navigate the National Medical Products Administration (NMPA) registration process. This involves appointing a registration legal agent in China to submit the application, as foreign companies cannot apply directly. (gacc.agency) The application dossier must adhere to the Common Technical Document (CTD) format, ensuring comprehensive and standardized documentation. For generic products, clinical trials may not be required, but bioequivalence studies are often necessary. The entire process typically spans 18 to 24 months, depending on the product type and regulatory requirements.

2GMP & Facility Requirements

China mandates that foreign manufacturing sites comply with Good Manufacturing Practice (GMP) standards as per NMPA regulations. The inspection process involves a thorough evaluation of manufacturing facilities to ensure adherence to these standards. While China has been working towards mutual recognition agreements with other countries, the extent of such recognition can vary, and companies should stay updated on the latest developments to facilitate smoother market entry.

3Import Documentation

To import pharmaceutical products into China, Indian exporters must provide several key documents:

Import License: Authorization from Chinese authorities permitting the importation of specific pharmaceutical products.

Certificate of Pharmaceutical Product (CPP): Issued by the exporting country's regulatory authority, confirming the product's compliance with national standards.

Certificate of Analysis (CoA): Details the product's specifications and quality control measures.

GMP Certificate: Verifies that the manufacturing facility adheres to GMP standards.

Additionally, customs procedures require detailed product information, including labeling and packaging compliance with Chinese regulations.

TransData Nexus Research · China regulatory databasesMar 2026

FAQ — India to China Pharmaceutical Trade

What is the total value of India's pharmaceutical export to China?

India exported pharmaceuticals worth $78.0M to China across 3,469 verified shipments.

Who are the top Indian pharmaceutical exporters to China?

1. DR.REDDY'S LABORATORIES LTD — $10.3M. 2. AP WAREHOUSING AND TRADING LLP — $6.3M. 3. MARK (INDIA) FORMULATION — $5.5M. Total: 201 suppliers.

Which companies in China import pharmaceuticals from India?

1. XXISSXXLOBXX TRXXE DXXC — $6.3M. 2. SINO UNIVERSAL PHARMACEUTICAL CO — $3.0M. 3. SHENZHEN FONCOO PHARMACEUTICAL CO., — $3.0M. 431 buyers total.

What pharmaceutical products does India export most to China?

1. 10000 Strips Sildenafil Citrate 100 MG ($5.9M, 7.5%); 2. Oseltamivir Phosphate Capsules 75 MG (1x10s) ($1.2M, 1.6%); 3. Oseltamivir Phosphate Capsules 75 MG (1x10's) ($1.1M, 1.4%); 4. Material No- 44087965 Voriconazole 200mg30fct Cn ($921.5K, 1.2%); 5. Pretomanid Tablets 200mg 26bt (5212 Packs X 26's=135512 ) ($889.8K, 1.1%)

Which ports handle pharmaceutical shipments from India to China?

Export: HYDERABAD ICD, SAHAR AIR CARGO ACC (INBOM4), J MATADEE - CHENNAI FTZ, HYDERABAD ICD (INSNF6), SAHAR AIR. Import: SHANGHAI - PU DONG, Dalian, SHANGHAI, Shenzhen, DALIAN.

Why does China import pharmaceuticals from India?

India's cost-competitive generic drug manufacturing, WHO-GMP certified facilities, and broad product portfolio. This $78.0M corridor reflects quality compliance and pricing advantages.

What certifications do Indian pharmaceutical exporters need to supply China?

WHO-GMP certification, EU GMP approval (for EU markets), product dossier registration (CTD format), and ICH guideline compliance.

What is the average shipment value for India to China pharmaceutical trade?

$22.5K per consignment across 3,469 shipments.

How many Indian pharmaceutical companies export to China?

201 Indian companies. Largest: DR.REDDY'S LABORATORIES LTD with $10.3M.

How can I find verified Indian pharmaceutical suppliers for China?

TransData Nexus covers 201 active exporters with shipment history and trade values at transdatanexus.com.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Data Source: Indian Customs (DGFT) export shipping bill records covering all pharmaceutical shipments from India.
2.Country Matching: Shipments to China identified using destination country codes from customs declarations.
3.Statistical Normalization: Values are statistically normalized to remove outlier transactions and ensure accurate market share representation.
4.Coverage: 3,469 verified shipments from 201 Indian exporters to 431 China buyers.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

201 Exporters

431 buyers tracked

Expert-Reviewed

By pharmaceutical trade specialists

India to China Pharmaceutical Export

Top Pharmaceutical Formulations — India to China

Top Pharmaceutical Products — India to China Trade Routes

Top Indian Exporters to China

Port Analysis — India to China Pharmaceutical Shipments

Indian Export Ports

China Import Ports

Trade Statistics

Other Destinations

India–China Pharmaceutical Trade Corridor Analysis

1Trade Corridor Evolution

2India's Market Position

Top China Buyers from India

Product Routes

Full Dataset Access

3Recent Developments

China Regulatory Landscape for Indian Pharmaceutical Exports

1Registration Process

2GMP & Facility Requirements

3Import Documentation

Product Categories & Therapeutic Trends — India to China

1Dominant Categories

2Emerging Opportunities

3Demand Drivers

Trade Policy & Tariff Intelligence — India and China

1Tariff & Duty Structure

2Trade Agreements

3IP & Patent Landscape

Supply Chain & Logistics — India to China Pharma Shipments

1Shipping Routes & Transit

2Port Infrastructure

3Cold Chain & Compliance

Market Opportunity Assessment — China for Indian Pharma

1Market Size & Growth

2Healthcare System

3Opportunity for Indian Exporters

Competitive Landscape — India vs Other Pharmaceutical Suppliers to China

1Competing Origins

2India's Competitive Edge